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ABSTRACT
Topoisomerases (topos) maintain DNA topology and
influence DNA transaction processes by catalysing
relaxation, supercoiling and decatenation reactions.
In the cellular milieu, division of labour between dif-
ferent topos ensures topological homeostasis and
control of central processes. In Escherichia coli,
DNA gyrase is the principal enzyme that carries
out negative supercoiling, while topo IV catalyses
decatenation, relaxation and unknotting. DNA
gyrase apparently has the daunting task of under-
taking both the enzyme functions in mycobacteria,
where topo IV is absent. We have shown previously
that mycobacterial DNA gyrase is an efficient
decatenase. Here, we demonstrate that the strong
decatenation property of the enzyme is due to its
ability to capture two DNA segments in trans.
Topo IV, a strong dedicated decatenase of E. coli,
also captures two distinct DNA molecules in a
similar manner. In contrast, E. coli DNA gyrase,
which is a poor decatenase, does not appear to be
able to hold two different DNA molecules in a stable
complex. The binding of a second DNA molecule to
GyrB/ParE is inhibited by ATP and the non-
hydrolysable analogue, AMPPNP, and by the substi-
tution of a prominent positively charged residue in
the GyrB N-terminal cavity, suggesting that this
binding represents a potential T-segment pos-
itioned in the cavity. Thus, after the GyrA/ParC
mediated initial DNA capture, GyrB/ParE would
bind efficiently to a second DNA in trans to form a
T-segment prior to nucleotide binding and closure
of the gate during decatenation.
INTRODUCTION
DNA topoisomerases (topos) facilitate many DNA trans-
action processes by altering the topology of DNA mol-
ecules, and are essential for cell survival (1–5). Based on
the mechanism used for inter-conversion of different topo-
isomers, the enzymes have been classified as type I or type
II (6), and further into IIA and IIB, on the basis of struc-
tural considerations (7). Type IIA topos, which occur in
all eubacteria and eukaryotes, bind and catalyse the
double-strand cleavage of a DNA segment, termed the
gate (G) segment, followed by the ATP-dependent
transfer of another duplex DNA, the transfer (T)
segment, through the break and subsequent religation of
the cleaved segment. Type IIA topos are the target of a
number of classes of cytotoxic compounds, which act to
stabilize the transient double-stranded break, leading to
DNA breakage and cell death. These include anti-tumour
agents targeting the human enzymes (8,9) and anti-bacter-
ial compounds, most notably the quinolones and fluoro-
quinolones (10,11).
Using this double-strand passage mechanism, type IIA
topos can relax both positive and negative supercoiling,
with a linking number change of ±2 per cycle (6,7,12),
and can also catalyse decatenation of the catenated inter-
mediates formed during replication (5,13), and can unknot
DNA (14). All cells require at least one type II topo, but
bacteria contain a specialized type IIA enzyme, DNA
gyrase, that can introduce negative supercoils using the
free energy of ATP hydrolysis (15). In Escherichia coli,
and many other bacteria, while gyrase is responsible for
the introduction of negative supercoils (15), as well as the
removal of positive supercoils ahead of replication and
transcription (4,16), the topo IV paralogue acts to
separate the catenated daughter replication products
(17,18), relax DNA (18,19) and remove potentially lethal
knots (14,20,21). Thus, topo IV preferentially carries out
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inter-molecular strand passage, resulting in decatenation,
while DNA gyrase primarily catalyses intra-molecular
strand passage, leading to the accumulation of negative
supercoils (22). This primary difference in the reactions
of the two enzymes appears to be conferred by a different
mode of selection of the substrate T-segment. In prokary-
otes, these enzymes are heterotetramers of two subunits,
one containing the active site tyrosine residue for the
cleavage and religation of the G-segment (GyrA in
gyrase, ParC in topo IV), the other (GyrB, ParE), the
ATPase active site (6,23). The selection of a particular
substrate by topo IV (24) or gyrase (25) depends upon
the geometry of the DNA, which is substantially
determined by the carboxy terminal domain (CTD) of
GyrA/ParC (24–26). Crystal structures of the CTD of
ParC (27) and GyrA (28) reveal the basis of this differen-
tial preference. The GyrA CTD adopts a b-pinwheel fold,
responsible for wrapping the DNA at either side of the
G-segment region. Gyrases thus bind 130 bp of DNA,
and the wrapping of DNA around the GyrA CTD serves
to position a contiguous T-segment in a cavity between the
GyrB N-terminal domains (29–31) for ‘capture’ by
dimerization of those domains on ATP binding (32–35),
leading to strand-passage and negative supercoiling. In
contrast, the ParC CTD contains a broken b-pinwheel
fold due to the absence of the ‘GyrA-box’ motif (27).
This reduces the curvature of the proposed DNA-
binding region, resulting in less efficient DNA bending
by ParC (24,27). Topo IV thus does not facilitate the se-
lection of a T-segment in cis, and is more likely to capture
a T-segment from another DNA molecule, resulting in
decatenation, and accordingly, the enzyme cannot super-
coil DNA, but is a strong decatenase. In contrast, gyrase
facilitates the introduction of negative supercoils and is a
very poor decatenase (22).
Unlike in E. coli, where a division of labour ensures
supercoiling and decatenation are performed by different
enzymes, in organisms of the genusMycobacteria, a single
type II enzyme appears to suffice. None of the mycobac-
terial species whose genome has so far been sequenced
possesses a topo IV homologue; DNA gyrase is the sole
type II topo in this genus with the exception of a second
type II enzyme with unusual properties in Mycobacterium
smegmatis (36). Several other eubacteria also lack topo IV
(37). Thus, in these organisms, either DNA gyrase carries
out the additional task of separating catenated daughter
chromosomes, or an alternative mechanism must have
evolved to perform this essential task (38). Since GyrA
and GyrB subunits from the two mycobacterial species
show only 40–44% identity to E. coli gyrase subunits,
they are likely to exhibit distinct properties. Accordingly,
we found that DNA gyrase from M. smegmatis is an effi-
cient decatenase (39). Mycobacterium tuberculosis DNA
gyrase has also been shown to be a potent decatenase
[(40); our unpublished results], suggesting that gyrase
could be carrying out this dual role in vivo in these
organisms.
In the present study, we have investigated what makes
the mycobacterial DNA gyrase able to perform efficient
decatenation, a task performed efficiently by topo IV,
which is functionally different from a typical DNA
gyrase. We present evidence for the efficient binding of
two separate DNA molecules by M. smegmatis gyrase, a
property that is shared with E. coli topo IV, but not with
the ‘typical’ E. coli gyrase. The binding site for the second
DNA in both the enzymes lies within their ATPase
subunits. The data are consistent with the idea that this
second DNA corresponds to the captured T-segment.
MATERIALS AND METHODS
Enzymes and chemicals
Oligonucleotides used in this study are listed in Supple-
mentary Table S1. DNA I (40 bp) contains the strong
gyrase site sequence mapped for mycobacterial gyrase
(39). DNA II (72 bp) contains 16 additional residues
flanking each side of the DNA I. DNA III (143 bp) is
PCR amplified using 50-end-labelled pUC18 forward and
unlabelled reverse primers, from pUC18 containing DNA
I cloned in the multiple cloning site. The 240-bp DNA was
PCR amplified from the pBR322 strong gyrase site
sequence (29). Oligonucleotides (MWG and Sigma
Aldrich) were gel purified and end labelled using T4 poly-
nucleotide kinase (NEB) and g-32P ATP (6000Ci/mmol).
Labelled oligonucleotides were further purified using a
1ml G-25 sephadex (Sigma Aldrich) spin column and
annealed to their respective complementary oligonucleo-
tides. Ampicillin, kanamycin, IPTG and acetamide were
from Sigma Aldrich. Purification of E. coli DNA gyrase,
M. smegmatis DNA gyrase and E. coli topo IV subunits
were carried out as described previously (19,39,41).
The R321A mutant of M. smegmatis GyrB was
generated using the megaprimer inverse PCR method
(42). The mutation was confirmed by sequencing. The
oligonucleotides used for mutagenesis are listed in
Supplementary Table S1. Mutant GyrB was purified fol-
lowing the protocol used for wild-type mycobacterial
GyrB. A plasmid based on pET17b (Novagen) was con-
structed for the expression of residues 1–391 of E. coli
ParE (pJR1, expressing ParE43). The R284Q mutation
was constructed using Quikchange mutagenesis
(Strategene) to replace a CGT with a CAG codon, and
confirmed by sequencing. The proteins were expressed in
E. coli strain B834 (DE3) pLysE (Novagen), by induction
with IPTG (0.4mM) and subsequently purified to homo-
geneity by heparin–Sepharose and Mono-Q Sepharose
(GE Healthcare) chromatography at pH 7.5. The
proteins were stored in 50mM Tris–HCl (pH 7.5),
100mM KCl, 5mM DTT, 1mM EDTA and 10% (w/v)
glycerol. Protein concentrations were determined using
Bradford’s method (43).
Electrophoretic mobility shift assay
Different concentrations of the protein (as indicated in the
Figure legends) were incubated with 1 nM of end-labelled
double-stranded DNA fragment (sizes as indicated in the
Figure legends) in supercoiling buffer (35mM Tris–HCl
pH 7.5, 1mM spermidine, 25mM potassium glutamate,
tRNA 90 mg/ml, 1.4mM ATP and BSA 50 mg/ml) at
room temperature for 15min. The complexes were
resolved on 5% native PAGE (0.5 TBE buffer). Gels
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were dried and exposed to phosphor imager film and
imaged by a Fujifilm phosphor imager (FLA 15 000).
Biotin pulldown assay
For biotin pulldown assays, 72-bp biotinylated oligo-
nucleotide was annealed to its complimentary oligonucleo-
tide (32P-labelled). The gyrase holoenzyme or subunits
were incubated first with either biotinylated DNA (72 bp)
or non-biotinylated 240-bp DNA in supercoiling reaction
buffer at 25C for 10min followed by the addition of the
other DNA. After 5min, streptavidin–sepharose beads
were added to each of the reaction and allowed to bind
to biotinylated DNA for 15min by continuous mixing.
The beads were pelleted by centrifugation and washed
using supercoiling reaction buffer. The pellet and the super-
natant fractions were analysed on a 7% urea PAGE. The
gels were dried and exposed to phosphor imager film and
imaged by Fujifilm phosphor imager FLA 15 000.
SPR-binding measurements
Surface plasmon resonance (SPR)-binding measurements
of ParE43 and the R284Q mutant to DNA were carried
out with a BIAcore X system (BIAcore). A 140-bp DNA
fragment, amplified from plasmid pBR322, and
biotinylated at one 50-end, was bound to a streptavidin
sensor chip. Measurements were carried out in 33mM
Tris–HCl (pH 8.0), 5mM MgCl2, 3mM DTT at a flow
rate of 30 ml min1 at 25C. Where indicated, the protein
was pre-incubated with ADPNP (0.5mM) for 30min at
37C. The data were analysed using BIAevaluation
software (BIAcore).
Crosslinking experiments
DNA gyrase or individual subunits were incubated with
50-end-labelled 72-bp DNA II (Supplementary Table S1)
in the presence or absence of ATP (as indicated) in the
supercoiling buffer for 30min on ice after which
crosslinking solution (37% formaldehyde and Methanol;
9:1) was added to a final concentration of 0.7%.
Crosslinking reactions were continued for 30min at
37C (44). The products were separated by 8% SDS–
PAGE and visualized using a phosphor imager.
Protein crosslinking assays were carried out using
glutaraldehyde. DNA gyrase subunits were mixed in a
1:1 ratio and incubated in supercoiling reaction buffer
on ice for 30min followed by the addition of 1 ml of
0.2% of glutaraldehyde. Reactions were shifted to 37C
for 30min, and terminated by the addition of SDS to a
final concentration of 0.1%. Crosslinked products were
resolved on 6% SDS–PAGE (30:1 acrylamide and
bisacrylamide ratio) and visualized by silver staining.
ATPase assay
The ATPase reactions were carried out in a buffer con-
taining 40mM Tris–HCl, pH 7.5, 5mM MgCl2, 10mM
DTT, 1mM spermidine, 20mM KCl, 1.4mM ATP and
0.02 mCi of [g-32P] ATP (6000Ci mmol1). To assess the
intrinsic ATPase activity, 100 nM of GyrB/ParE subunits
andM. smegmatisDNA gyrase/ topo IV holoenzyme were
used. For DNA-dependent stimulation of ATPase
activity, 100 or 400 nM of 72-bp DNA was added as
indicated. The assays were carried out at 37C for
60min followed by chloroform extraction. The aqueous
layer (1ml) was resolved on polyethyleneimine-cellulose
thin layer chromatography using 1.2M LiCl, and
0.1mM EDTA as mobile phase. The spots of ATP and
Pi were visualized using a phosphor imager and quan-
titated using Image gauge software. ATPase assays of
ParE43 and the R284Q mutant were carried out using a
pyruvate kinase–lactate dehydrogenase coupled system in
50mM Tris–HCl, 5mM DTT, 100mM KCl, 2mMMgCl2
and 2mMATP at 37C, including concentrations of linear
pBR322 DNA (4361 bp) as described (45).
Supercoiling and decatenation
Three-hundred nanograms of pUC18 DNA relaxed with
E. coli Topo I was used as a substrate for supercoiling
reactions with 25 nM of either E. coli or M. smegmatis
DNA gyrase. The reactions were carried out in supercoil-
ing buffer at 37C for 30min and terminated by the
addition of 0.1% SDS (final concentration) followed by
proteinase K (50 mg/ml) treatment for 1 h at 37C. The
topoisomers were resolved on 1.2% agarose gels.
Decatenation assays were carried out using Leishmania
donovani kDNA. An amount of 25 nM of the enzyme and
300 ng of kDNA were used for each reaction. The assays
were carried out as described earlier (39) and terminated
by the addition of gel-loading dye (0.6% SDS, 0.25%
bromophenol blue, 0.25% xylene cyanol, 1mM EDTA
and 5% glycerol) followed by heat inactivation at 75C
for 10min. Released minicircles were resolved on 1.2%
agarose gels stained with ethidium bromide. The gels
were visualized in a Biorad gel documentation system.
Filter-binding assay
Filter-binding assays were carried out using a 12-well
Millipore filtration apparatus and 0.45-mm pore-sized
nitrocellulose filters (Millipore). Reaction mixtures
(20ml) were as described for electrophoretic mobility
shift assay (EMSA). An amount of 20 nM of GyrB
(M. smegmatis and E. coli) and ParE (E. coli) were used
for binding to 72-bp DNA. After incubating for 10min on
ice, the assay mixtures were spotted on nitrocellulose
filters, loaded on the filtration apparatus and pre-washed
with a wash buffer (1ml) containing 35mM Tris–HCl,
10% (v/v) glycerol, 0.1mM EDTA, 50mM NaCl and
2mM 2-mercaptoethanol. After 5min, each filter was
washed twice with 1ml of wash buffer to remove any
non-specifically bound DNA. The filters were dried and
counts retained were measured by scintillation counter.
RESULTS
Experimental design
The essential difference between the two major reactions
catalysed by type II topos is the mode of T-segment
capture. For a supercoiling reaction involving intra-
molecular strand passage, gyrase has to capture the
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T-segment in cis. In contrast, topo IV has to capture a
separate DNA in trans for inter-molecular strand
passage during the decatenation reaction. We therefore
hypothesize that a good decatenase, such asM. smegmatis
DNA gyrase, must be able to bind efficiently to a second
DNA segment, in addition to the G-segment. Thus, we
compared the DNA-binding properties of M. smegmatis
and E. coli gyrase to DNA fragments of varying sizes,
using EMSA and DNA crosslinking assays. E. coli topo
IV, a very strong decatenase, was also used to monitor the
DNA binding in control experiments.
Mycobacterium smegmatis DNA gyrase can bind two
DNA molecules
We monitored binding of different length DNA substrates
by EMSA, using both M. smegmatis and E. coli gyrase
(Figure 1 and Supplementary Figure S1). With the
shortest DNA (40 bp), formation of only one complex
was seen with both the gyrases irrespective of the
enzyme concentration (Figure 1A and E). In contrast,
two complexes were observed using a 72-bp DNA, at
lower concentrations of the mycobacterial gyrase;
increasing the enzyme concentration led to the formation
of a single slower mobility complex (Figure 1B), suggest-
ing the possibility of binding two DNA molecules inde-
pendently to the same enzyme. Similar results were
obtained with a 143-bp DNA; a faster moving species
was converted into a supershifted complex at the highest
enzyme concentration (Figure 1C). In contrast, when we
used a much larger DNA (240 bp), only one complex was
formed (Figure 1D). Equivalent assays carried out with E.
coli gyrase revealed only one complex with all the DNA
molecules (40–240 bp) used (Figure 1E–H).
To further assess the properties of the two DNA-
binding sites, the ability of the quinolone drugs to stabilize
a covalent complex with a cleaved G-segment was used.
Stabilization of binding using a quinolone should ensure
that a DNA fragment is bound as a G-segment, allowing
binding of additional DNA fragments to be investigated.
Moxifloxacin (MFX) was used in these experiments, since
it is a better inhibitor of mycobacterial gyrase than other
fluoroquinolones (39). As seen previously, gyrase can form
a well-defined complex with a 240-bp DNA (Figure 2,
Lane 1), which is unaffected by the subsequent addition
of 72-bp DNA, with or without pre-treatment with MFX
(Lane 2, Lane 4). However, when the 72-bp DNA and the
M. smegmatis enzyme were initially trapped in a covalent
complex using MFX, followed by the addition of 240-bp
DNA, a supershifted complex was formed (Lane 3). In
contrast, E. coli gyrase did not show any evidence of a
supershifted complex containing both DNAs (Lanes 6–8).
Taken together, these experiments suggest that
M. smegmatis DNA gyrase can bind two separate DNA
segments, but binding of a long fragment initially as a
G-segment inhibits the subsequent binding of a second
fragment, presumably because the 240-bp fragment is
able to form a proficient DNA wrap, and additionally
fill the second DNA-binding site, potentially the site of
T-segment binding.
To confirm that mycobacterial gyrase has the ability to
bind two different DNA molecules efficiently, biotin
pulldown assays were also carried out using biotinylated
72-bp and untagged 240-bp fragments (Supplementary
Figure S2A); the experimental design is described in the
Supplementary Figure S2B and in ‘Materials and
Methods’ section. When the 72-bp DNA was added to
mycobacterial gyrase first, followed by the 240-bp, both
the DNAs were found predominantly in the pellet
fraction, suggesting that the enzyme had bound both
DNAs. In contrast, when the order of DNA addition
was reversed i.e. with the initial binding of a larger
segment, only shorter biotinylated DNA was predomin-
antly found in the pellet (Supplementary Figure S2C).
Using E. coli gyrase, co-precipitation of the two fragments
was much less efficient. These results are consistent with
the data from mobility shift experiments described above.
Only with mycobacterial gyrase and a short G-segment is
efficient binding of the second DNA molecule seen.
Mycobacterium smegmatis GyrB binds DNA
To further analyse the distinct DNA-binding sites in
M. smegmatis gyrase and determine to which subunit of
the enzyme the second DNA molecule is bound, DNA
crosslinking experiments were carried out using the holo-
enzymes and individual subunits. The holoenzymes, as
well as both GyrAs, generated crosslinked species.
Surprisingly, mycobacterial GyrB alone could crosslink
to DNA while no crosslinked species was seen with
E. coli GyrB (Figure 3A). To verify these results, EMSA
was performed using the GyrB subunits from E. coli and
M. smegmatis. Mycobacterial GyrB was found to bind
DNA, while no detectable DNA-bound complex could
be seen in the case of E. coli GyrB (Figure 3B). A more
sensitive filter-binding assay was carried out to further
assess the binding by GyrB subunits. In these assays,
binding of both mycobacterial and E. coli GyrBs to
DNA could be detected, although the lower degree of
binding seen with E. coli GyrB would explain the inability
to see the complex in EMSA (Figure 3C).
The two GyrB subunits dimerize in presence of ATP
(33), forming the nucleotide operated (N) gate (34,46),
with an internal cavity responsible for trapping the
T-segment (35,47). This dimerization may influence the
DNA-binding properties of GyrB. To test this, we
carried out crosslinking experiments in the presence of
ATP. The crosslinking of DNA to the M. smegmatis B
subunit was reduced in presence of ATP (Supplementary
Figure S3A). Binding of ATP and/or its hydrolysis thus
leads to reduced interaction of GyrB subunit with DNA.
To verify these results, 50-adenylyl-b,g-imidodiphosphate
(AMPPNP), a non-hydrolysable analogue of ATP, was
used in place of ATP in the crosslinking experiments.
Formation of DNA–protein complex was reduced to a
great extent when AMPPNP was incubated with GyrB
before the addition of DNA (Figure 3C and Supplemen-
tary Figure S3B), indicating that the closure of the N gate
induced by the non-hydrolysable analogue of ATP
affected the DNA binding by GyrB.
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GyrB subunits from different bacteria exhibit low level
intrinsic ATPase activity, which is stimulated in the
presence of DNA (48,49). ATPase assays were carried
out in the absence and presence of duplex DNA using
M. smegmatis DNA gyrase and its GyrB subunit alone
to monitor whether DNA binding influenced the
ATPase activity. The intrinsic ATPase activity of the
subunit was stimulated >2-fold in the presence of DNA
(Figure 3D). In contrast, ATPase activity of E. coli GyrB
was not enhanced by DNA to a significant extent (data
not shown), substantiating its poor interaction with the
DNA shown in Figure 3C. M. smegmatis gyrase holoen-
zyme also showed a DNA-dependent increase in the
ATPase activity, but the level of stimulation was almost
equal to that found for GyrB alone, suggesting that the
stimulation of the activity is because of DNA binding to
GyrB. The ATPase activity was novobiocin-sensitive
(Figure 3D), confirming that it was due to the GyrB
subunit (50,51).
Second DNA binding is an exclusive property of GyrB
The above results strongly suggest a role for GyrB in
capturing the second segment of DNA. However, to
verify whether the GyrA or the holoenzyme take part in
the process and to further establish the DNA-binding
function of mycobacterial GyrB, interspecies heterote-
trameric gyrases were reconstituted (Figure 4A).
Crosslinking experiments carried out to verify heterotetra-
merization showed that E. coli GyrA can form a
heterotetramer with M. smegmatis GyrB and similarly,
M. smegmatis GyrA with E. coli GyrB. These crosslinked
hybrids migrate similarly in the gel to their parent holo-
enzymes (Figure 4B). Heterotetramerization of the
interspecies subunits was also verified by gel filtration;
M. smegmatis GyrB was found to be co-eluting with
E. coli GyrA and similarly M. smegmatis GyrA with E.
coli GyrB (data not shown). The interspecies
heterotetramers were catalytically active in the supercoil-
ing reaction (Figure 5A). While the activity of the myco-
bacterial GyrA and E. coli GyrB hybrid was comparable
to the parent holoenzymes, the heterotetramer containing
the E. coli GyrA and mycobacterial GyrB showed reduced
supercoiling activity (Figure 5A). However, importantly,
this hybrid enzyme retained stronger decatenase activity
(Figure 5B), a characteristic of mycobacterial gyrase
(Figure 5B). E. coli DNA gyrase, as expected showed
Figure 1. DNA-binding properties of M. smegmatis and E. coli DNA gyrase. EMSA carried out with increasing concentrations of MsGyr
(M. smegmatis) or EcGyr (E. coli) gyrase with radioactively labelled DNA molecules of different lengths. DNA binding with MsGyr (A–D) and
EcGyr (E–H). The reactions were carried out at 25C and then resolved on 5% native polyacrylamide gels using 0.5 TBE buffer and visualized
using a phosphorimager. The arrows indicate two DNA-bound complexes in (B) and (C). Details of the reactions are given in ‘Materials and
Methods’ section. For sequences of the DNA molecules refer to Supplementary Table S1.
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lower decatenation activity (39). The interspecies hybrids
were analysed for their DNA-binding characteristics by
EMSA. The re-constituted heterotetramers bound DNA,
and importantly, E. coli GyrA and M. smegmatis GyrB
complex could bind to two DNA molecules, similar to
M. smegmatis DNA gyrase holoenzyme. The other
mixed heterotetramer having M. smegmatis GyrA and
E. coli GyrB was found to bind only one DNA, like
E. coli DNA gyrase holoenzyme (Figure 5C). From
these observations, we deduce that the binding to the
second DNA molecule is an intrinsic property of GyrB
subunit and GyrA subunit or the holoenzyme does not
appear to influence the process in a significant fashion.
DNA binding by ParE and stimulation of ATPase activity
The ability of mycobacterial DNA gyrase to capture two
separate DNA molecules may enable it to act as a strong
decatenase, by allowing it to capture a T-segment in trans.
To further test this proposition, we investigated the
binding of DNA to E. coli topo IV, one of the strongest
known decatenases (13,19,52), using the same experimen-
tal strategy. EMSA with E. coli topo IV showed the for-
mation of two bound complexes (Figure 6A). Biotin
pulldown experiments with topo IV (Supplementary
Figure S4, similar to the experiments described for
gyrase in Supplementary Figure S2) confirmed the above
finding. Next, to check whether this property of binding to
second DNA is conferred by ParE (the homologue of
GyrB in topo IV), we carried out EMSA with the 72-bp
DNA. ParE subunit alone was found to be able to
bind DNA (Figure 6B). Filter-binding assays showed
that DNA binding by ParE was most efficient among
the proteins tested (Figure 3C). Furthermore, the intrinsic
low-level ATPase activity of ParE was enhanced >3-fold
by the addition of DNA (Figure 6C). In a separate set of
experiments, ParE43 ATPase domain (the amino terminal
43-kDa fragment of ParE, Supplementary Figure S5)
bound DNA and the binding is greatly reduced in
presence of non-hydrolysable ATP analogue (Supplemen-
tary Figure S5), similar to the behaviour of mycobacterial
GyrB (Supplementary Figure S3B). The ParE43 ATPase
domain showed 4-fold stimulation of ATPase activity in
the presence of linear DNA (Figure 6D). Topo IV holo-
enzyme also showed DNA-dependent stimulation of
ATPase activity (Figure 6C). However, the stimulation
appears to be ParE-specific as in the case of GyrB from
M. smegmatis (Figure 3D); the increased activity of the
holoenzyme was to the same extent as that of ParE,
indicating that ParE is mainly responsible for binding to
the second DNA fragment.
A conserved arginine residue within the ATPase domain is
required for efficient second DNA binding
The crystal structure of the 43-kDa GyrB (35) and ParE
(32) subunits from E. coli revealed an arginine residue in
the cavity of the ATPase domain that is found to be
conserved in other type IIA topos and which may have
a role in DNA binding. The side chain of this arginine
protrudes into the cavity formed by the ParE dimer.
This arginine is also found in M. smegmatis GyrB
(R321), although the protein shows only 40% identity to
E. coli GyrB. The mutation of this conserved arginine to
alanine in M. smegmatis GyrB (R321A) significantly
reduced the DNA-binding ability of the mutant. As a
Figure 2. EMSA of M. smegmatis and E. coli gyrase with 72- and 240-bp DNA. DNA gyrase (50 nM) was incubated with DNA and 2 mg/ml MFX
at 37C for 10min and then shifted back to ice before adding the second DNA. The 72- and 240-bp DNA used were the same as in Figure 1. Lane
1—MsGyr+240 bp, Lane 2—MsGyr+240 bp!72 bp (where the arrow-head indicates order of addition), Lane 3—MsGyr+72 bp+MFX!240 bp,
Lane 4—MsGyr+240 bp+MFX!72 bp, Lane 5—Free 72- and 240-bp DNA, Lane 6-EcGyr+72 bp, Lane 7-EcGyr+240 bp, Lane 8—
EcGyr+72 bp+MFX!240 bp. The complexes were resolved on a 5% native polyacrylamide gel and visualized using a phosphor imager. The
pictograms indicate the likely mode of binding of the DNAs to the gyrase holoenzymes.
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result, a DNA–protein complex is not seen in EMSA
(Figure 7A). A filter-binding assay also showed reduction
in the binding ability of the R321A GyrB (data not
shown). Importantly, the holoenzyme reconstituted with
R321A GyrB was unperturbed in supercoiling activity
(Figure 7B) but found to be compromised in its decate-
nation ability (Figure 7C and D). The reduced DNA-
binding efficiency of the R321A also resulted in the
diminished DNA-dependent stimulation of the ATPase
activity of the individual subunit or the reconstituted holo-
enzyme (Supplementary Figure S6A and B). This is con-
sistent with the effect of an R284Q mutation, the
homologous position in E. coli ParE in reducing the
DNA binding (Supplementary Figure S5) and stimulation
of ATPase activity of the ParE43 from 4-fold in the
wild-type to 1.6-fold in the mutant (Figure 6D).
DISCUSSION
In the reaction mechanism proposed for DNA gyrase, the
CTD of GyrA is involved in wrapping the DNA around
the holoenzyme, allowing a T-segment from the same
molecule to enter the GyrB clamp (53). While this
mechanism explains the intra-molecular strand passage
required for gyrase supercoiling, it is not clear how topo
IV and other non-supercoiling type II enzymes, which use
a T-segment from another DNA molecule during
decatenation, capture DNA into the ParE / ATPase
subunit clamp. We have demonstrated that both
M. smegmatis DNA gyrase and E. coli topo IV, but not
E. coli gyrase, can bind to two DNA fragments; this
ability is thus correlated with significant decatenation
activity. The first complex appears to be due to the
binding of G-segment DNA, as judged by the stabilization
of this complex by MFX. Experiments with isolated
GyrB/ParE subunits, and subunit swapping suggest that
the second DNA binding is conferred by GyrB/ParE. The
reduction in this binding caused by pre-closure of the
clamp with AMPPNP, or by substitution of a prominent
arginine residue on the inner surface of the GyrB/ParE
cavity in both M. smegmatis GyrB and E. coli ParE
strongly suggest that the second DNA binds in the
GyrB/ParE cavity, forming a T-segment.
Different type II topos have preference for a particular
geometry of the substrate recognized by their respective
CTD of the cleavage religation subunit (7,25,27,28,54).
Figure 3. DNA binding by GyrB. (A) Crosslinking of DNA gyrase holoenzymes and individual subunits from M. smegmatis and E. coli with 72-bp
DNA. An amount of 100 nM of GyrA subunit and 1 mM of each of the GyrB subunits were used for individual subunit crosslinking. The holo-
enzymes were reconstituted by mixing the 100 nM of GyrA subunit with 200 nM of the respective GyrB subunits. DNA crosslinking with gyrase and
its individual subunits was carried out as described in ‘Materials and Methods’ section and the products were resolved on an 8% SDS–PAGE. Lane
1—DNA only, Lane 2—EcGyr, Lane 3—MsGyr, Lane 4—EcGyrA, Lane 5—MsGyrA, Lane 6—EcGyrB and Lane 7—MsGyrB; (B) EMSA with
72-bp DNA using MsGyrB and EcGyrB (0.1 and 0.2 mM) subunits. The DNA-bound complexes were resolved on a 5% native polyacrylamide gel;
(C) Filter-binding assay with 20 nM each of MsGyrB, EcGyrB and E. coli ParE (EcParE) using 72-bp DNA. Enzyme was pre-incubated with 2mM
AMPPNP before addition of DNA (where indicated); (D) DNA (72 bp)-mediated stimulation of ATPase activity. ATPase assays were carried out
with MsGyr (100 nM) or its GyrB subunit (100 nM) in the absence and presence of 72-bp DNA (400 nM). Lane 1—MsGyrB alone, Lane 2—
MsGyrB+DNA, Lane 3—MsGyr alone, Lane 4—MsGyr+DNA and Lane 5—MsGyr+Novobiocin (10 mg/ml). The error bars represent standard
deviation across three measurements.
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The CTD of GyrA wraps the DNA in cis to bring it inside
the GyrB clamp as a T-segment (53). Removal of the CTD
of E. coli GyrA converts it into a conventional non-
supercoiling type IIA topo (55), which can relax supercoils
in the presence of ATP. This C-terminal truncation
enhances decatenation activity of E. coli gyrase suggesting
that the CTD may exert a negative effect on decatenation
activity. Additionally, the CTD of ParC and GyrA show
remarkable sequence and structural differences (24,25).
The presence of a b-strand bearing proline in the GyrA
CTD introduces an out of plane twist in the b-pinwheel
domain, causing an abrupt bend in the DNA-binding
surface, thus contributing to the unique negative super-
coiling activity of DNA gyrase (56). ParC CTD, on the
other hand has been shown to contain a broken b-pin-
wheel domain different from that of GyrA CTD, resulting
in lower DNA bending (27). These structural studies
indicated that GyrA/ParC CTD curvature may determine
the enzyme’s ability to present the T-segment
(25,27,55,56). Our present studies suggest that an add-
itional DNA-binding site in the ATPase cavity is
required for efficient T-segment capture in a decatenation
reaction.
The ATPase domain of human Topo IIa has also been
shown to bind DNA, resulting in stimulation of its
ATPase activity (57,58). Plasmodium falciparum GyrB
subunit which is selectively localized to a specialized or-
ganelle termed the apicoplast, has been shown to bind
DNA and the binding stimulates its ATPase activity
(59). A point to be noted is that, in the apicoplast
genome, decatenation would be a prerequisite when the
organelle divides along with the parasite after the replica-
tion process. These studies also point towards the import-
ance of the ATPase subunit in capturing the T-segment.
The interaction of Drosophila type II topo at DNA cross-
overs has also suggested the binding to an additional
DNA-binding site (60). All these observations suggest
the need for efficient capture of a second DNA in a
decatenation reaction. However, the exact mechanism by
which ATPase domain captures DNA during the process
remains to be understood.
From the analysis of GyrB/ParE sequences, it is rather
difficult to predict which of the residues contribute to
DNA binding. Distribution of the basic amino acid
patches over a large surface of GyrB/ParE renders such
analysis a daunting task. Although high-resolution
Figure 4. Swapping of subunits between MsGyr and EcGyr forms active heterotetramers. (A) Schematic representation of the experiment.
MsGyrB—blue; MsGyrA—red; EcGyrB—green; EcGyrA—turquoise; (B) Glutaraldehyde crosslinking to show heterotetramer formation by
EcGyrA+EcGyrB, MsGyrA+MsGyrB and MsGyrA+EcGyrB and EcGyrA+MsGyrB. The subunits were mixed and incubated on ice for
30min. Crosslinking reaction with glutaraldehyde (final concentration—0.01%) was carried out at 37C for 30min. Native and crosslinked
proteins were separated on 8% SDS–PAGE.
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Figure 6. DNA binding and ATPase activity of E. coli topoIV and its ParE subunit (A) EMSA with E. coli topo IV holoenzyme (5–40 nM) using
72-bp DNA. The arrows indicate two DNA-bound complexes; (B) EMSA with increasing concentrations of ParE (5–100 nM) subunit using 72-bp
DNA. The reaction conditions were similar to those used for Figure 1; (C) ATP hydrolysis by the topo IV holoenzyme and ParE (100 nM of each)
subunit in the absence and presence of 72-bp (100 nM) DNA; (D) ATPase activity of wild-type and R284Q mutant ParE43 fragment (2mM dimer), in
the presence and absence of linear pBR322 at a ratio of 25-bp DNA per protein dimer. The activity is expressed as the apparent kcat of the protein
dimer in the presence of 2mM ATP. The error bars represent the standard deviation of three measurements.
Figure 5. Topoisomerase activity of interspecies heterotetramers. (A) Supercoiling assay with the interspecies heterotetramers and the parent holo-
enzymes (25 nM). An amount of 300 ng relaxed pUC18 plasmid was used as substrate for the supercoiling assay. The topoisomers were resolved on a
1.2% agarose gel; (B) Decatenation activity of the parent and interspecies heterotetramers (25 nM) using 300 ng of kinetoplast DNA as substrate. The
details of the reaction are given in ‘Materials and Methods’ section; (C) EMSA carried out with increasing concentrations (nM) of reconstituted
hybrid heterotetramers (EAMB (EcGyrA+MsGyrB), MAEB (MsGyrA+EcGyrB) and MsGyr. 72-bp DNA was used as substrate. The DNA-bound
complexes were resolved on a 5% native polyacrylamide gel. Arrows indicate the two complexes formed.
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structures of intact GyrB/ParE are not available, the
structural analysis of the ATPase domain of GyrB and
ParE subunit of E. coli showed an arginine from each
monomer protruding into the cavity (32,35). Mutation
of this residue (R284Q) in the ATPase domain of E. coli
ParE (ParE43) resulted in decreased stimulation of
ATPase activity (Figure 6D) and reduced DNA binding
(Supplementary Figure S5), similar to results with the
homologous mycobacterial GyrB mutant described in
this manuscript (Figure 7A and Supplementary Figure
S6). Notably, the holoenzyme comprising the R321A
GyrB retained its supercoiling activity (Figure 7B) but
the decatenation activity was affected (Figure 7C
and D). In contrast, the mutation in the conserved
arginine in E. coli GyrB (R286Q) led to the loss of both
supercoiling and decatenation activities (47). Taken
together, these results suggest that the arginine has an
important role in T-segment interaction. However, the
presence of this arginine is not a crucial determinant of
decatenation activity, since the residue is conserved in
many other ‘normal’ gyrase sequences in addition to
E. coli GyrB; rather these results point to the importance
of efficient capture of a T-segment in the GyrB cavity for
decatenation activity. Since the mutation of the residue in
the two gyrases show somewhat different properties, it is
likely that additional residues are involved in the efficient
binding of the T-segment in case of mycobacterial GyrB
and E. coli ParE.
While the supercoiling activities of DNA gyrase from
E. coli and M. smegmatis are comparable, they differ sig-
nificantly in their decatenation ability (39). Based on our
present findings, we predict a strong decatenation activity
for DNA gyrase from diverse bacteria that lack topo IV.
In all eubacteria containing a single type II topo, DNA
gyrase may have the task of catalysing both the supercoil-
ing and decatenation reactions. An interesting question is
whether and how the enzyme is able to switch from a
supercoiling to a decatenation mode at the end of DNA
replication and other intracellular situations that require
untangling of DNA. In our experiments, we have
demonstrated that altering substrate DNA length can
reveal the additional DNA-binding site in mycobacterial
GyrB or E. coli ParE. With a long DNA substrate
(240 bp), a single binding event is observed indicating
that GyrA CTD-mediated writhing step facilitates
intra-strand capture, thus favouring the supercoiling
Figure 7. DNA-binding activity of the wild-type (wt) and R321A GyrB subunit. (A) EMSA with 200 and 400 nM each of wt MsGyrB and its R321A
mutant. The reaction conditions were similar to those used for Figure 2B. The 72-bp DNA was used as binding substrate; (B) DNA supercoiling of
the mycobacterial gyrase reconstituted by mixing the wt or the R321A GyrB with GyrA subunit. An amount of 25 nM of M. smegmatis gyrase was
reconstituted by mixing 25 nM of GyrA with 50 nM of either wt or R321A GyrB. The details of the reaction are given in ‘Materials and Methods’
section; (C) Decatenation assay with the holoenzyme reconstituted by mixing 25 nM of GyrA with 50 nM of either wt or R321A GyrB. An amount
of 300 ng of kDNA was used as substrate. The decatenated minicircles were resolved on a 1.2% agarose gel; (D) Quantitation of the decatenation
(released minicircles) by the wt and R321A GyrB containing holoenzyme from M. smegmatis (in Figure 7C) using Fujifilm multigauge V2.3.
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reaction. Indeed electron microscopic studies carried out
earlier with M. luteus gyrase demonstrated looped struc-
tures indicating the intra-strand capture of the T-segment
with longer DNA molecules (61). When shorter DNA
fragments were used in the reaction, the mycobacterial
gyrase was able to capture two distinct DNA molecules,
a prerequisite for decatenation. When a very small-length
DNA (40 bp) was used, it formed only one bound complex
(Figure 1A), perhaps because of the inability of the GyrB
to bind smaller DNA (data not shown). Earlier studies
have suggested that DNA <50 bp can be used as a
G-segment which is not effective as T-segment (62).
However, gyrase would be present on a long DNA
molecule in vivo and hence, this will not suffice to
explain the distinction between two styles of reaction.
One possibility is that under some conditions, perhaps
when negative supercoiling is high, the torsion in the
DNA opposing the positive wrap would allow an
inter-molecular T-segment to compete more easily with
the wrapped T-segment. Topo-interacting proteins could
also play a major role in this switch in vivo, as
demonstrated in case of topo IV of E. coli (63).
To conclude, efficient capture of the transfer segment by
the ATPase subunit of type IIA topos is a key event during
the decatenation process. While the CTD of the DNA
breakage/religation subunit (GyrA/ParC) has determin-
ants for recognition of the appropriate substrate for
strand cleavage and discrimination between DNA of dif-
ferent topologies (24,25), capture of the T-segment seems
to be an exclusive property of the ATPase subunit of the
strong decatenases. In principle, inhibition of the binding
of the second DNA to the enzyme would inhibit the
overall reaction of the topos. The present studies hence
open up the possibility of new strategies for the design
of novel classes of gyrase inhibitors against the mycobac-
terial enzyme and possibly for other strong decatenases.
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